Eascra Biotech is a company that develops therapeutic nanotechnologies. It offers nanomaterials for treating articular cartilage, central nervous system disorders, solid tumors, and other chronic conditions. The company also delivers JBNp, a platform for mRNA therapeutics and gene editing; JBNm, a cell-free injectable scaffold for orthopedic applications involving cartilage repair and regeneration; and JBNm-Tissue Chip, which simulates knee joints on a microchip for biomedical research and drug testing.